Respiree, Roche announces AI integration for RPM
Singaporean startup Respiree has tied up with global pharmaceutical and diagnostics company Roche for technology integration.
Respiree will be combining its vital sign monitoring device with Roche's blood glucose device as a joint bedside offering. The solution is also expected to be integrated with machine learning models that predict clinical...
Pharmaceutical and diagnostics giant Roche has recently integrated a suite of AI algorithms into its enterprise digital pathology software.
The company has collaborated with South Korean firm Deep Bio to power the navify digital pathology platform with the prostate cancer analysis AI solution, DeepDx Prostate. The AI technology provides pathologists with gland-level Gleason grading, measurements...
Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators.
The alliances aim to support pathologists and scientists in cancer research and diagnosis by leveraging AI.
The pharma giant will integrate the third-party AI tools into its navify Digital Pathology...
Diabetes and insulin management software company Glytec and pharmaceutical firm Roche are teaming up to allow the use of Glytec's software in connection with Roche's point-of-care smart-device hospital blood glucose system cobas pulse in the U.S. and global markets.
According to Roche, cobas pulse's strip architecture provides lab-like results and minimizes the need to repeat tests. The system...
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition closes.
LumiraDx developed a diagnostic testing system that uses a small, portable instrument and microfluidic test strips to perform multiple lab-quality tests via a single...
Health technology company PicnicHealth, pharma giant Roche and its subsidiary Genentech are expanding their partnership globally to speed up neurological disease research through investments in real-world data.
PicnicHealth allows patients to see their health history and contribute their de-identified medical data to clinical research.
Roche will leverage PicnicHealth's newest real-world...
South Korea clears Coreline Soft's AI brain haemorrhage detection software
An AI-powered brain haemorrhage detection software by medtech company Coreline Soft is now listed as a non-insured medical device in South Korea following its approval from the Ministry of Food and Drug Safety.
The software product called AVIEW Neuro CAD automatically detects cerebral haemorrhages in brain CT scans and...
Roche Pharma India has launched a mobile patient app for those taking part in its cancer support programme.
The company's flagship patient assistance programme Blue Tree caters to cancer, haemophilia and rare disease patients. Over 11,000 patients are currently enrolled in this programme.
A new companion mobile app called Blue Tree 2.0 is improving access to the services of this programme. Roche...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to offer Kaiku's tools for symptom management and support to clinics and patients.
Finnish-born Kaiku provides a digital platform where patients can input their symptoms as they undergo cancer treatment, receive feedback for lower-acuity concerns and keep the care team...
